Charles River Announces Fourth-Quarter and Full-Year 2008 Results and 2009 Guidance
Downloadable version.
- Company Records Goodwill Impairment of $700.0 Million, or $10.43 per Share
- Fourth-Quarter GAAP Loss per Share of $9.91 Including the Charge, and Non-GAAP Earnings per Share of $0.59
- Full-Year GAAP Loss per Share of $7.76 Including the Charge and Non-GAAP Earnings per Share of $2.89
- 2009 Guidance of GAAP EPS Between $1.86-$2.16 and Non-GAAP EPS Between $2.30-$2.60
- Company to Repatriate $90 Million of Foreign Earnings in First Quarter of 2009
WILMINGTON, Mass.--(BUSINESS WIRE)--Feb. 9, 2009--Charles River Laboratories International, Inc. (NYSE: CRL) today reported its results for the fourth-quarter and full-year 2008 and provided guidance for 2009. For the quarter, net sales decreased 2.1% to $311.4 million from $318.0 million in the fourth quarter of 2007. Higher sales for the Research Models and Services (RMS) segment were offset by lower sales for the Preclinical Services (PCS) segment and by foreign exchange, which decreased sales growth by 4.2%.
Click here to read the full release.
Click here to download a set of frequently asked questions that provide more in-depth information for our customers about this release.